ZOM vs. XOM

In the year-to-date period, ZOM achieves a 0.83% return, which is significantly lower than XOM's 1.52% return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for Zomedica Corp. (ZOM) and Exxon Mobil Corporation (XOM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current ZOM Sharpe Ratio is -0.15, which is lower than the XOM Sharpe Ratio of 0.54. The chart below compares the historical Sharpe Ratios of ZOM and XOM, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

ZOM has not paid dividends to shareholders, while XOM's dividend yield for the trailing twelve months is around 3.58%.

The maximum ZOM drawdown since its inception was -97.75%, which is greater than XOM's maximum drawdown of -62.40%. Use the drawdown chart below to compare losses from any high point for ZOM and XOM. For additional features, visit the drawdowns tool.

Zomedica Corp. (ZOM) and Exxon Mobil Corporation (XOM) have volatilities of 6.36% and 6.68%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.

This section allows you to compare key financial metrics between Zomedica Corp. and Exxon Mobil Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.